The FluMist vaccine can now be self-administered after the FDA approved its use to treat the influenza disease.

The spray could be an alternative for people who are averse to getting injections, or otherwise find it difficult or ...

FluMist is the first vaccine to prevent influenza, more commonly known as the flu, that does not need to be administered by a ...

The FDA approved the first flu vaccine that does not have to be administered by a health care provider, but it won’t be available in time for this respiratory virus season.

And now, there’s growing interest in other nasal spray products such as vaccines and even life-saving medications. For years ...

Pediatric patients are also more susceptible to becoming addicted to ketamine and forming substance abuse disorders.

The vaccine FluMist, manufactured by MedImmune, which was acquired by AstraZeneca in 2007, was first approved by the FDA in 2003 for individuals between five and 49 years of age. Its approval has ...

In a first, the US Food and Drug Administration on Friday approved a nasal spray flu vaccine for self-administration ...

The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the first “self-administered” influenza vaccine — though a delay in the change ...

The nasal spray option could encourage more people who have fears of doctors or needles to inoculate themselves against the ...

The FDA Friday approved the flu vaccine that can be done at home and does not need to be administered by a health care provider.

Dr. Curiel says vaccines in nasal form target the airway, where a respiratory virus enters the body. “A systemic injection, like MRNA, will augment antibodies in the blood, not so much in the lung.